Cargando…
An “all-in-one” antitumor and anti-recurrence/metastasis nanomedicine with multi-drug co-loading and burst drug release for multi-modality therapy
Drug-loading often suffers from tedious procedures, limited loading efficiency, slow release, and therefore a low curative effect. Cancer easily recurs and metastasizes even after a solid tumor is removed. Herein, we report a simple strategy with multi-drug co-loading and burst drug release for a hi...
Autores principales: | Yang, Ji-Chun, Shang, Yue, Li, Yu-Hao, Cui, Yu, Yin, Xue-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148201/ https://www.ncbi.nlm.nih.gov/pubmed/30288240 http://dx.doi.org/10.1039/c8sc02305k |
Ejemplares similares
-
Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition
por: Huang, Ran, et al.
Publicado: (2023) -
Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution
por: Strittmatter, Nicole, et al.
Publicado: (2022) -
A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery
por: Yang, Conglian, et al.
Publicado: (2018) -
High drug-loading nanomedicines: progress, current status, and prospects
por: Shen, Shihong, et al.
Publicado: (2017) -
The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC
por: Marwitz, Sebastian, et al.
Publicado: (2020)